Apathy Diagnosis , Assessment , and Treatment in Alzheimer ’ s Disease

doi: 10.1111/j.1755-5949.2009.00132.x Apathy is defined as a disorder of motivation. There is wide acknowledgement that apathy is an important behavioral syndrome in Alzheimer’s disease and in various neuropsychiatric disorders. In light of recent research and the renewed interest in the correlates and impacts of apathy and in its treatments, it is important to develop criteria for apathy that will be widely accepted, have clear operational steps, and be easy to apply in clinical practice and in research settings. Meeting these needs was the focus for a task force that included members of the European Psychiatric Association, the European Alzheimer’s Disease Consortium and experts from Europe, Australia and North America.

[1]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[2]  J. Gerlach,et al.  Behavioral aspects of serotonin-dopamine interaction in the monkey. , 1985, European journal of pharmacology.

[3]  A. Phillips,et al.  Dopamine and preparatory behavior: I. Effects of pimozide. , 1987, Behavioral neuroscience.

[4]  R. Marin Differential diagnosis and classification of apathy. , 1990, The American journal of psychiatry.

[5]  R. Marin,et al.  Reliability and validity of the apathy evaluation scale , 1991, Psychiatry Research.

[6]  R. Marin,et al.  Apathy: a neuropsychiatric syndrome. , 1991, The Journal of neuropsychiatry and clinical neurosciences.

[7]  H. Mayberg,et al.  Reliability, validity, and clinical correlates of apathy in Parkinson's disease. , 1992, The Journal of neuropsychiatry and clinical neurosciences.

[8]  J. T. Coull,et al.  Tryptophan depletion in normal volunteers produces selective impairments in learning and memory , 1994, Neuropharmacology.

[9]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[10]  Joseph James Duffy,et al.  Apathy: a treatable syndrome. , 1995, The Journal of neuropsychiatry and clinical neurosciences.

[11]  B L Miller,et al.  Cerebral blood flow correlates of apathy in Alzheimer disease. , 1996, Archives of neurology.

[12]  K. Yoshimoto,et al.  Possibility of 5-HT3 receptor involvement in alcohol dependence: a microdialysis study of nucleus accumbens dopamine and serotonin release in rats with chronic alcohol consumption. , 1996, Alcoholism, clinical and experimental research.

[13]  S. Kapur,et al.  Serotonin-dopamine interaction and its relevance to schizophrenia. , 1996, The American journal of psychiatry.

[14]  P. De Deurwaerdère,et al.  Serotonin Enhances Striatal Dopamine Outflow In Vivo Through Dopamine Uptake Sites , 1996, Journal of neurochemistry.

[15]  K. Berridge Food reward: Brain substrates of wanting and liking , 1996, Neuroscience & Biobehavioral Reviews.

[16]  O. Magnusson,et al.  Influence of 5-HT1B/1D receptors on dopamine release in the guinea pig nucleus accumbens: a microdialysis study , 1997, Neuroscience Letters.

[17]  S. Walsh,et al.  Serotonergic mechanisms involved in the discriminative stimulus, reinforcing and subjective effects of cocaine , 1997, Psychopharmacology.

[18]  M. Millan,et al.  Serotonin (5-HT)2C receptors tonically inhibit dopamine (DA) and noradrenaline (NA), but not 5-HT, release in the frontal cortex in vivo , 1998, Neuropharmacology.

[19]  Art Noda,et al.  A Follow-Up Study of Actigraphic Measures in Home-Residing Alzheimer's Disease Patients , 1998, Journal of geriatric psychiatry and neurology.

[20]  P. De Deurwaerdère,et al.  Opposite Change of In Vivo Dopamine Release in the Rat Nucleus Accumbens and Striatum That Follows Electrical Stimulation of Dorsal Raphe Nucleus: Role of 5-HT3 Receptors , 1998, The Journal of Neuroscience.

[21]  K. Berridge,et al.  What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? , 1998, Brain Research Reviews.

[22]  S. Kapur,et al.  Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. , 1999, The American journal of psychiatry.

[23]  M. Posner The Brain and Emotion , 1999, Nature Medicine.

[24]  T. Robbins,et al.  Tryptophan depletion impairs stimulus-reward learning while methylphenidate disrupts attentional control in healthy young adults: implications for the monoaminergic basis of impulsive behaviour , 1999, Psychopharmacology.

[25]  B. Winblad,et al.  The occurrence of depressive symptoms in the preclinical phase of AD , 1999, Neurology.

[26]  N. Volkow,et al.  Association between age-related decline in brain dopamine activity and impairment in frontal and cingulate metabolism. , 2000, The American journal of psychiatry.

[27]  Kelly J. Murphy,et al.  Differentiation of states and causes of apathy. , 2000 .

[28]  Richard G. Brown,et al.  Negative symptoms: the ‘pathology’ of motivation and goal-directed behaviour , 2000, Trends in Neurosciences.

[29]  A. Kelley,et al.  Serotonin-Dopamine Interactions in the Control of Conditioned Reinforcement and Motor Behavior , 2001, Neuropsychopharmacology.

[30]  G. Malandain,et al.  Perfusion Brain SPECT and Statistical Parametric Mapping Analysis Indicate That Apathy Is a Cingulate Syndrome: A Study in Alzheimer's Disease and Nondemented Patients , 2001, NeuroImage.

[31]  S. Starkstein,et al.  Syndromic validity of apathy in Alzheimer's disease. , 2001, The American journal of psychiatry.

[32]  Charles J. Wilson,et al.  Cholinergic interneuron characteristics and nicotinic properties in the striatum. , 2002, Journal of neurobiology.

[33]  H. Caci,et al.  The Apathy Inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment , 2002, International journal of geriatric psychiatry.

[34]  Jacques Darcourt,et al.  Brain perfusion in Alzheimer's disease with and without apathy: a SPECT study with statistical parametric mapping analysis , 2002, Psychiatry Research: Neuroimaging.

[35]  K. Berridge,et al.  Erratum to: “Parsing reward” [Trends Neurosci. 26 (2003) 507–513] , 2003, Trends in Neurosciences.

[36]  P. Boyle,et al.  Treating Apathy in Alzheimer’s Disease , 2003, Dementia and Geriatric Cognitive Disorders.

[37]  K. Berridge,et al.  Parsing reward , 2003, Trends in Neurosciences.

[38]  K. Berridge Comparing the emotional brains of humans and other animals. , 2003 .

[39]  Saori C. Tanaka,et al.  Prediction of immediate and future rewards differentially recruits cortico-basal ganglia loops , 2004, Nature Neuroscience.

[40]  A. Pfeffer,et al.  Prevalence of major and minor depression in elderly persons with mild cognitive impairment—MADRS factor analysis , 2004, International journal of geriatric psychiatry.

[41]  T. Svensson,et al.  Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition , 2004, Psychopharmacology.

[42]  J. Darcourt,et al.  Brain perfusion correlates of the apathy inventory dimensions of Alzheimer's disease , 2004, International journal of geriatric psychiatry.

[43]  L. Provinciali,et al.  Motivational Symptoms of Depression Mask Preclinical Alzheimer’s Disease in Elderly Subjects , 2004, Dementia and Geriatric Cognitive Disorders.

[44]  P. Scheltens,et al.  Behavioral symptoms in mild cognitive impairment , 2004, Neurology.

[45]  Magda Tsolaki,et al.  Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium , 2005, European Psychiatry.

[46]  D. Stuss,et al.  Apathy: why care? , 2005, The Journal of neuropsychiatry and clinical neurosciences.

[47]  J. Becker,et al.  Non-cognitive symptoms in mild cognitive impairment subjects , 2005, Neurocase.

[48]  R. Robinson,et al.  A prospective longitudinal study of apathy in Alzheimer’s disease , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[49]  Karl Herholz,et al.  Regional cerebral metabolism in early Alzheimer’s disease with clinically significant apathy or depression , 2005, Biological Psychiatry.

[50]  C. Jack,et al.  Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI , 2005, Neurology.

[51]  R. Mizrahi,et al.  On the overlap between apathy and depression in dementia , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[52]  Masayuki Matsuda,et al.  Four subgroups of Alzheimer's disease based on patterns of atrophy using VBM and a unique pattern for early onset disease , 2006, NeuroImage.

[53]  J Darcourt,et al.  Lack of initiative and interest in Alzheimer's disease: a single photon emission computed tomography study , 2006, European journal of neurology.

[54]  P Sockeel,et al.  The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson’s disease , 2006, Journal of Neurology, Neurosurgery & Psychiatry.

[55]  B. Dubois,et al.  Neuropsychological Performance in Mild Cognitive Impairment with and without Apathy , 2006, Dementia and Geriatric Cognitive Disorders.

[56]  René Hen,et al.  Hippocampal Neurogenesis: Regulation by Stress and Antidepressants , 2006, Biological Psychiatry.

[57]  B. Dubois,et al.  Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. , 2006, Cerebral cortex.

[58]  Afshin Borhani Haghighi,et al.  Does Serotonin Augmentation Have Any Effect on Cognition and Activities of Daily Living in Alzheimer's Dementia?: A Double-Blind, Placebo-Controlled Clinical Trial , 2007, Journal of clinical psychopharmacology.

[59]  S. Walther,et al.  Actigraphy in agitated patients with dementia. Monitoring treatment outcomes. , 2007, Zeitschrift fur Gerontologie und Geriatrie.

[60]  B. Dubois,et al.  Importance of lack of interest in patients with mild cognitive impairment. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[61]  Annalena Venneri,et al.  Neuroanatomical correlates of neuropsychiatric symptoms in Alzheimer's disease. , 2008, Brain : a journal of neurology.

[62]  B. Vellas,et al.  P3-135: Course of neuropsychiatric symptoms during a four year follow-up in the REAL-FR cohort , 2008, Alzheimer's & Dementia.

[63]  A. Leentjens,et al.  The nosological position of apathy in clinical practice , 2008, Journal of Neurology, Neurosurgery, and Psychiatry.

[64]  H. Lavretsky Neuropsychiatric symptoms in Alzheimer disease and related disorders: why do treatments work in clinical practice but not in the randomized trials? , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[65]  B. Vellas,et al.  Apathy and depression in Alzheimer's disease are associated with functional deficit and psychotropic prescription , 2008, International journal of geriatric psychiatry.

[66]  H. Caci,et al.  Striatal dopamine transporter levels correlate with apathy in neurodegenerative diseases A SPECT study with partial volume effect correction , 2008, Clinical Neurology and Neurosurgery.

[67]  Lippincott Williams Wilkins,et al.  THERMOREGULATION: RECENT CONCEPTS AND REMAINING QUESTIONS , 2008, Neurology.

[68]  F. Verhey,et al.  Pharmacological Treatment of Apathy in Neurodegenerative Diseases: A Systematic Review , 2009, Dementia and Geriatric Cognitive Disorders.

[69]  M Benoit,et al.  Persistent apathy in Alzheimer's disease as an independent factor of rapid functional decline: the REAL longitudinal cohort study , 2009, International journal of geriatric psychiatry.

[70]  K. Dujardin,et al.  Proposed diagnostic criteria for apathy in Alzheimer’s disease and other neuropsychiatric disorders , 2009, European Psychiatry.

[71]  David Eidelberg,et al.  Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease. , 2009, Brain : a journal of neurology.

[72]  G. Bernardi,et al.  Dopamine Modulates Cholinergic Cortical Excitability in Alzheimer's Disease Patients , 2009, Neuropsychopharmacology.

[73]  A. Padovani,et al.  Differential Impact of Apathy and Depression in the Development of Dementia in Mild Cognitive Impairment Patients , 2009, Dementia and Geriatric Cognitive Disorders.

[74]  P. Andersen,et al.  Antidepressants and dementia. , 2009, Journal of affective disorders.